Alpine Peaks Capital’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.99M Sell
9,418
-1,938
-17% -$894K 5.84% 6
2026
Q1
$5.45M Buy
11,356
+1,850
+19% +$947K 5.5% 7
2025
Q4
$5.34M Sell
9,506
-3,200
-25% -$1.82M 5.08% 8
2025
Q3
$6.53M Sell
12,706
-7,600
-37% -$3.32M 5.67% 6
2025
Q2
$6.37M Sell
20,306
-1,600
-7% -$480K 5.62% 6
2025
Q1
$6.67M Buy
21,906
+800
+4% +$269K 6.02% 4
2024
Q4
$7.01M Sell
21,106
-7,403
-26% -$2.51M 5.76% 6
2024
Q3
$9.52M Buy
28,509
+1,350
+5% +$513K 5.68% 5
2024
Q2
$11.2M Sell
27,159
-1,000
-4% -$396K 6.87% 4
2024
Q1
$11.4M Sell
28,159
-11,770
-29% -$4.14M 6.56% 3
2023
Q4
$12.2M Buy
39,929
+1,850
+5% +$499K 7.44% 2
2023
Q3
$9.22M Buy
38,079
+1,375
+4% +$352K 6.43% 3
2023
Q2
$8.82M Hold
36,704
6.19% 3
2023
Q1
$6.9M Buy
36,704
+3,753
+11% +$776K 5.21% 7
2022
Q4
$7M Sell
32,951
-5,635
-15% -$1.13M 5.67% 4
2022
Q3
$6.07M Buy
38,586
+12,680
+49% +$2.02M 5.44% 4
2022
Q2
$3.88M Buy
25,906
+2,300
+10% +$333K 4.52% 12
2022
Q1
$3.86M Buy
23,606
+6,700
+40% +$1.1M 3.97% 14
2021
Q4
$3.68M Buy
+16,906
New +$3.54M 3.6% 17

Other funds holding MEDP

Alpine Peaks Capital's MEDP Position: Q2 2026 in Review

Alpine Peaks Capital reduced its Medpace (MEDP) stake by 17% in Q2 2026, selling an estimated $894K and leaving 9,418 shares worth $4.99M. The position accounts for 5.84% of the portfolio, ranked #6.

Alpine Peaks Capital first reported a position in MEDP in Q4 2021 and has held it in 19 quarters since. The position peaked at $12.2M in Q4 2023. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Alpine Peaks Capital held 9,418 shares of Medpace worth $4.99M as of Q2 2026.
  • Alpine Peaks Capital sold 1,938 Medpace shares in Q2 2026, an estimated $894K.
  • Medpace made up 5.84% of Alpine Peaks Capital's portfolio in Q2 2026, its #6 holding.
  • Alpine Peaks Capital first reported a position in Medpace in Q4 2021 and has held it in 19 quarters since.
  • Alpine Peaks Capital's Medpace position peaked at $12.2M in Q4 2023.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Alpine Peaks Capital's 13F filing for Q2 2026, filed 14 Aug 2026.